What level of efficacy is seen in adolescent patients vs the overall population of patients on ritlecitinib?
Featuring Glynis Ablon, MD | Associate Clinical Professor University of California, Los Angeles Ablon Skin Institute & Research Center Los Angeles, CA | Published December 02, 2024
Related Media
Powered by Polaris TM